NeuroNEXT UO1 Funding Announcement

The National Institute of Neurological Disorders and Stroke (NINDS) has re-issued the FOA for cooperative agreement grants: NeuroNEXT Clinical Trials (UO1) PAR-13-343.  This NIH FOA will expire on 8/4/2017.  For more information on this, please click on the following link.